AERAS-456
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AERAS-456, covering 2019-08-21 to 2019-12-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456) [Phase 1, Phase 2]